Diffuse infantile fibromatosis

Diffuse Infantile Fibromatosis is a rare and benign, yet aggressive, fibrous tumor that predominantly affects infants and young children. This condition is characterized by the proliferation of fibroblasts, which are cells that produce collagen and other fibers, leading to the development of tumors within the affected individual's soft tissues. Despite its aggressive nature, Diffuse Infantile Fibromatosis is considered non-malignant because it does not metastasize like cancerous tumors. However, its tendency to infiltrate surrounding tissues can lead to significant complications, depending on the tumor's location.

Etiology

The exact cause of Diffuse Infantile Fibromatosis remains unknown. It is believed to arise from a complex interplay of genetic and environmental factors. Some studies suggest a potential link to genetic mutations, but no specific genes have been conclusively identified as being responsible for the condition.

Pathophysiology

In Diffuse Infantile Fibromatosis, there is an abnormal proliferation of fibroblasts. These fibroblasts produce an excess of fibrous tissue, leading to the formation of tumors. The tumors can occur in various parts of the body, including but not limited to, the muscles, subcutaneous tissues, and even internal organs. The excessive fibrous tissue can interfere with the normal function of the affected organs and tissues, causing a range of symptoms.

Symptoms

The symptoms of Diffuse Infantile Fibromatosis vary widely depending on the tumor's location and size. Common symptoms include:

• A palpable mass or swelling in the affected area
• Pain or tenderness in the affected area
• Restricted movement if the tumor is near joints
• Potential complications such as intestinal obstruction or respiratory distress if the tumor affects internal organs

Diagnosis

Diagnosis of Diffuse Infantile Fibromatosis involves a combination of clinical evaluation, imaging studies, and histopathological analysis. Imaging studies such as MRI (Magnetic Resonance Imaging) and CT scan (Computed Tomography) can help in assessing the extent of the tumor and its effect on surrounding tissues. A definitive diagnosis is usually made through a biopsy, where a sample of the tumor tissue is examined under a microscope to identify the characteristic fibroblastic cells.

Treatment

Treatment options for Diffuse Infantile Fibromatosis vary based on the tumor's location, size, and the presence of symptoms. Treatment strategies may include:

• Surgical removal of the tumor, which is the most common treatment approach. Complete excision is preferred to minimize the risk of recurrence.
• Corticosteroids or non-steroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain.
• Chemotherapy and radiation therapy are less commonly used but may be considered in cases where surgical removal is not feasible.

Prognosis

The prognosis for individuals with Diffuse Infantile Fibromatosis is generally favorable, especially when the tumor can be completely removed surgically. However, the condition has a high recurrence rate, necessitating regular follow-up and monitoring for any signs of recurrence.

See Also

• Fibromatosis
• Fibroblast
• Soft tissue tumor

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian